Ironvine Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6M | Sell |
|
|||||
|
2025
Q1 | $38.3M | Buy |
|
|||||
|
2024
Q4 | $37.9M | Sell |
|
|||||
|
2024
Q3 | $48.1M | Buy |
|
|||||
|
2024
Q2 | $42.9M | Sell |
|
|||||
|
2024
Q1 | $45.1M | Buy |
|
|||||
|
2023
Q4 | $41M | Sell |
|
|||||
|
2023
Q3 | $40.7M | Buy |
|
|||||
|
2023
Q2 | $41.5M | Sell |
|
|||||
|
2023
Q1 | $46.3M | Buy |
|
|||||
|
2022
Q4 | $44.1M | Buy |
|
|||||
|
2022
Q3 | $38.6M | Buy |
|
|||||
|
2022
Q2 | $39.6M | Buy |
|
|||||
|
2022
Q1 | $42.4M | Buy |
|
|||||
|
2021
Q4 | $46.8M | Sell |
|
|||||
|
2021
Q3 | $45.9M | Buy |
|
|||||
|
2021
Q2 | $39.2M | Buy |
|
|||||
|
2021
Q1 | $24.8M | Buy |
|
|||||
|
2020
Q4 | $25M | Sell |
|
|||||
|
2020
Q3 | $26.9M | Buy |
|
|||||
|
2020
Q2 | $22M | Buy |
|
|||||
|
2020
Q1 | $17.2M | Buy |
|
|||||
|
2019
Q4 | $16.9M | Buy |
|
|||||
|
2019
Q3 | $14.5M | Buy |
|
|||||
|
2019
Q2 | $13.3M | Buy |
|
|||||
|
2019
Q1 | $11.8M | Buy |
|